Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

Delayed Data
As of Mar 27
 +0.64 / +1.91%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 33 analysts offering 12-month price forecasts for Novo Nordisk have a median target of 38.91, with a high estimate of 49.78 and a low estimate of 29.20. The median estimate represents a +13.82% increase from the last price of 34.18.

Analyst Recommendations

The current consensus among 33 polled investment analysts is to Hold stock in Novo Nordisk. This rating has held steady since March, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 8.53%
Growthannually 3.18%


Growthquarterly -3.53%
Growthannually 5.78%
Key to the earnings and sales forecast charts.